4/16
09:15 am
arwr
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses [Yahoo! Finance]
Low
Report
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 6.6% drop adds to a year losses [Yahoo! Finance]
4/10
11:28 am
arwr
Leerink Taps Rothschild's Hotchandani for Health-Care Dealmaking [BNN Bloomberg (Canada)]
Low
Report
Leerink Taps Rothschild's Hotchandani for Health-Care Dealmaking [BNN Bloomberg (Canada)]
4/7
09:06 am
arwr
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo [Yahoo! Finance]
Low
Report
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo [Yahoo! Finance]
4/7
09:00 am
arwr
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
Low
Report
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
4/3
08:24 am
arwr
RegCell Appoints Leading T-Cell Therapy Expert Steven B. Kanner, Ph.D., to Board of Directors [Yahoo! Finance]
Low
Report
RegCell Appoints Leading T-Cell Therapy Expert Steven B. Kanner, Ph.D., to Board of Directors [Yahoo! Finance]
4/1
04:30 pm
arwr
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3/30
05:31 am
arwr
Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) [Seeking Alpha]
Low
Report
Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) [Seeking Alpha]
3/26
10:14 am
arwr
MIRUS BIO NAMED A TOP WORKPLACE BY THE WISCONSIN STATE JOURNAL [Yahoo! Finance]
Low
Report
MIRUS BIO NAMED A TOP WORKPLACE BY THE WISCONSIN STATE JOURNAL [Yahoo! Finance]
3/25
08:20 am
arwr
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data [Yahoo! Finance]
Low
Report
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data [Yahoo! Finance]
3/25
08:00 am
arwr
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
Low
Report
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
3/8
11:37 pm
arwr
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares [Yahoo! Finance]
High
Report
Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 40,000 Shares [Yahoo! Finance]
3/8
07:33 am
arwr
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy [Yahoo! Finance]
Low
Report
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy [Yahoo! Finance]
3/8
07:30 am
arwr
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
Low
Report
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
3/6
07:38 am
arwr
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic Value [Yahoo! Finance]
Low
Report
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic Value [Yahoo! Finance]
3/4
07:30 am
arwr
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
Medium
Report
Arrowhead Pharmaceuticals to Participate in Upcoming March 2024 Conferences
2/8
03:36 pm
arwr
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
2/8
08:11 am
arwr
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Morgan Stanley from $34.00 to $36.00. They now have an "equal weight" rating on the stock.
Low
Report
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Morgan Stanley from $34.00 to $36.00. They now have an "equal weight" rating on the stock.
2/8
06:46 am
arwr
Arrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Low
Report
Arrowhead Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
2/7
02:46 pm
arwr
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Citigroup Inc. from $33.00 to $34.00. They now have a "neutral" rating on the stock.
Low
Report
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its price target raised by analysts at Citigroup Inc. from $33.00 to $34.00. They now have a "neutral" rating on the stock.
2/7
12:34 pm
arwr
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $50.00 price target on the stock.
Low
Report
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $50.00 price target on the stock.
2/7
10:57 am
arwr
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
2/6
04:48 pm
arwr
Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ... [Yahoo! Finance]
Medium
Report
Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ... [Yahoo! Finance]
2/6
04:01 pm
arwr
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
Medium
Report
Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results
2/6
04:22 am
arwr
Global Viral Sensitizers Market Research Report 2023-2035: Development of Gene Therapy Breakthroughs and Surging Demand for Vaccines Emerge as Key Drivers [Yahoo! Finance]
Medium
Report
Global Viral Sensitizers Market Research Report 2023-2035: Development of Gene Therapy Breakthroughs and Surging Demand for Vaccines Emerge as Key Drivers [Yahoo! Finance]
1/31
08:46 am
arwr
Mirus Bio Receives ISO 13485:2016 Certification [Yahoo! Finance]
Low
Report
Mirus Bio Receives ISO 13485:2016 Certification [Yahoo! Finance]